Tag: immune thrombocytopenia purpura

Long-term dual antiplatelet therapy does not increase mortality risk

Takeda’s Mezagitamab Delivers Sustained Platelet Boost In Phase 2 Clinical Trials For Treatment of Immune Thrombocytopenia Purpura

byUsamah Bhaiduand1 others

July 10, 2024

Mezagitamab achieved a sustained platelet response and symptomatic relief in patients treated for chronic ITP. Mezagitamab showed a favorable safety ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Surgery is associated with an increased quality of life in women with endometriosis
Bougie-guided and stylet-guided intubation may have similar success rate in the intubation of trauma patients
Joint fusion superior to watchful waiting for hallux rigidus

No Result

View All Result